IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Novo Nordisk A/S ADR

Q2 2026 vs Q3 2026

Comparing institutional holders between quarters

Quarters

Q3 2026Q2 2026Q1 2026Q4 2024Q1 2023
CompareDetailedHistoricalFundsOptions13D/13GPeersTargetingTrading SummaryProfile
Asset Planning,Inc
UNCHANGED
Shares5,150 from 5,150
Change0 (0%)
Value$195.2K (-$51.7K)
Filed 2026-10-26
Status
Asset Planning,Inc
UNCHANGED5,1505,15000%$246.9K$195.2K-$51.7K2026-10-26
Showing 1 of 1 institutions